Content Summary
Since the device was specific to this medication, we needed to recruit users who were already
prescribed the drug and represented a small subset of the osteoporosis population. Additional
challenges included limited site availability and diagnosis confusion. However, because this trial was not testing a new medication and offered compensation, motivation to take part was high amongst eligible patients.
Access this content
Choose an option below
Your content has been opened.
Register to access this content
Verify your email to access this content
Code sent. Enter it in the modal
Your content has been opened.
Why do I need to verify I’m human?
Please verify you are a human before opening this content.
Your content has been opened.
The content will open in a new window. You may need to allow popups for this site.